Global Companion Diagnostics Market Insights And Forecast To 2028

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Immunohistochemistry (IHC)
1.2.4 In Situ Hybridization (ISH)
1.2.5 Next Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global Companion Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostics Market Perspective (2017-2028)
2.2 Companion Diagnostics Growth Trends by Region
2.2.1 Companion Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Companion Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Companion Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Companion Diagnostics Market Dynamics
2.3.1 Companion Diagnostics Industry Trends
2.3.2 Companion Diagnostics Market Drivers
2.3.3 Companion Diagnostics Market Challenges
2.3.4 Companion Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostics Players by Revenue
3.1.1 Global Top Companion Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Companion Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostics Revenue
3.4 Global Companion Diagnostics Market Concentration Ratio
3.4.1 Global Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics Revenue in 2021
3.5 Companion Diagnostics Key Players Head office and Area Served
3.6 Key Players Companion Diagnostics Product Solution and Service
3.7 Date of Enter into Companion Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostics Breakdown Data by Type
4.1 Global Companion Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Companion Diagnostics Forecasted Market Size by Type (2023-2028)
5 Companion Diagnostics Breakdown Data by Application
5.1 Global Companion Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Companion Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Companion Diagnostics Market Size (2017-2028)
6.2 North America Companion Diagnostics Market Size by Type
6.2.1 North America Companion Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Companion Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Companion Diagnostics Market Share by Type (2017-2028)
6.3 North America Companion Diagnostics Market Size by Application
6.3.1 North America Companion Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Companion Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Companion Diagnostics Market Share by Application (2017-2028)
6.4 North America Companion Diagnostics Market Size by Country
6.4.1 North America Companion Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Companion Diagnostics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Companion Diagnostics Market Size (2017-2028)
7.2 Europe Companion Diagnostics Market Size by Type
7.2.1 Europe Companion Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Companion Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Companion Diagnostics Market Share by Type (2017-2028)
7.3 Europe Companion Diagnostics Market Size by Application
7.3.1 Europe Companion Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Companion Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Companion Diagnostics Market Share by Application (2017-2028)
7.4 Europe Companion Diagnostics Market Size by Country
7.4.1 Europe Companion Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Companion Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Companion Diagnostics Market Size by Type
8.2.1 Asia-Pacific Companion Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Companion Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Companion Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Companion Diagnostics Market Size by Application
8.3.1 Asia-Pacific Companion Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Companion Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Companion Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Companion Diagnostics Market Size by Region
8.4.1 Asia-Pacific Companion Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Companion Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Companion Diagnostics Market Size (2017-2028)
9.2 Latin America Companion Diagnostics Market Size by Type
9.2.1 Latin America Companion Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Companion Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Companion Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Companion Diagnostics Market Size by Application
9.3.1 Latin America Companion Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Companion Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Companion Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Companion Diagnostics Market Size by Country
9.4.1 Latin America Companion Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Companion Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Companion Diagnostics Market Size by Type
10.2.1 Middle East & Africa Companion Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Companion Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Companion Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Companion Diagnostics Market Size by Application
10.3.1 Middle East & Africa Companion Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Companion Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Companion Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Companion Diagnostics Market Size by Country
10.4.1 Middle East & Africa Companion Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Companion Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Company Details
11.1.2 Roche Holdings Business Overview
11.1.3 Roche Holdings Companion Diagnostics Introduction
11.1.4 Roche Holdings Revenue in Companion Diagnostics Business (2017-2022)
11.1.5 Roche Holdings Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Companion Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Companion Diagnostics Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Companion Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2017-2022)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Companion Diagnostics Introduction
11.4.4 Agilent Technologies Revenue in Companion Diagnostics Business (2017-2022)
11.4.5 Agilent Technologies Recent Developments
11.5 Life Technologies
11.5.1 Life Technologies Company Details
11.5.2 Life Technologies Business Overview
11.5.3 Life Technologies Companion Diagnostics Introduction
11.5.4 Life Technologies Revenue in Companion Diagnostics Business (2017-2022)
11.5.5 Life Technologies Recent Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Companion Diagnostics Introduction
11.6.4 GE Healthcare Revenue in Companion Diagnostics Business (2017-2022)
11.6.5 GE Healthcare Recent Developments
11.7 Agendia
11.7.1 Agendia Company Details
11.7.2 Agendia Business Overview
11.7.3 Agendia Companion Diagnostics Introduction
11.7.4 Agendia Revenue in Companion Diagnostics Business (2017-2022)
11.7.5 Agendia Recent Developments
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Companion Diagnostics Introduction
11.8.4 Qiagen Revenue in Companion Diagnostics Business (2017-2022)
11.8.5 Qiagen Recent Developments
11.9 Genomic Health
11.9.1 Genomic Health Company Details
11.9.2 Genomic Health Business Overview
11.9.3 Genomic Health Companion Diagnostics Introduction
11.9.4 Genomic Health Revenue in Companion Diagnostics Business (2017-2022)
11.9.5 Genomic Health Recent Developments
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Details
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Companion Diagnostics Introduction
11.10.4 Myriad Genetics Revenue in Companion Diagnostics Business (2017-2022)
11.10.5 Myriad Genetics Recent Developments
11.11 Advanced Cell Diagnostics
11.11.1 Advanced Cell Diagnostics Company Details
11.11.2 Advanced Cell Diagnostics Business Overview
11.11.3 Advanced Cell Diagnostics Companion Diagnostics Introduction
11.11.4 Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2017-2022)
11.11.5 Advanced Cell Diagnostics Recent Developments
11.12 Danaher
11.12.1 Danaher Company Details
11.12.2 Danaher Business Overview
11.12.3 Danaher Companion Diagnostics Introduction
11.12.4 Danaher Revenue in Companion Diagnostics Business (2017-2022)
11.12.5 Danaher Recent Developments
11.13 Applied Proteomics
11.13.1 Applied Proteomics Company Details
11.13.2 Applied Proteomics Business Overview
11.13.3 Applied Proteomics Companion Diagnostics Introduction
11.13.4 Applied Proteomics Revenue in Companion Diagnostics Business (2017-2022)
11.13.5 Applied Proteomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Companion Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Immunohistochemistry (IHC)
Table 4. Key Players of In Situ Hybridization (ISH)
Table 5. Key Players of Next Generation Sequencing (NGS)
Table 6. Global Companion Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Companion Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Companion Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Companion Diagnostics Market Share by Region (2017-2022)
Table 10. Global Companion Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Companion Diagnostics Market Share by Region (2023-2028)
Table 12. Companion Diagnostics Market Trends
Table 13. Companion Diagnostics Market Drivers
Table 14. Companion Diagnostics Market Challenges
Table 15. Companion Diagnostics Market Restraints
Table 16. Global Companion Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Companion Diagnostics Revenue Share by Players (2017-2022)
Table 18. Global Top Companion Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2021)
Table 19. Ranking of Global Top Companion Diagnostics Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Companion Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Companion Diagnostics Product Solution and Service
Table 23. Date of Enter into Companion Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Companion Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Companion Diagnostics Revenue Market Share by Type (2017-2022)
Table 27. Global Companion Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Companion Diagnostics Revenue Market Share by Type (2023-2028)
Table 29. Global Companion Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Companion Diagnostics Revenue Share by Application (2017-2022)
Table 31. Global Companion Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Companion Diagnostics Revenue Share by Application (2023-2028)
Table 33. North America Companion Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Companion Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Companion Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Companion Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Companion Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Companion Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Companion Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Companion Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Companion Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Companion Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Companion Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Companion Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Companion Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Companion Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Companion Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Companion Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Companion Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Companion Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Companion Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Companion Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Companion Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Companion Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Companion Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Companion Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Companion Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Companion Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Companion Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Companion Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Companion Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Companion Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 63. Roche Holdings Company Details
Table 64. Roche Holdings Business Overview
Table 65. Roche Holdings Companion Diagnostics Product
Table 66. Roche Holdings Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 67. Roche Holdings Recent Developments
Table 68. Abbott Laboratories Company Details
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Companion Diagnostics Product
Table 71. Abbott Laboratories Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 72. Abbott Laboratories Recent Developments
Table 73. Thermo Fisher Scientific Company Details
Table 74. Thermo Fisher Scientific Business Overview
Table 75. Thermo Fisher Scientific Companion Diagnostics Product
Table 76. Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 77. Thermo Fisher Scientific Recent Developments
Table 78. Agilent Technologies Company Details
Table 79. Agilent Technologies Business Overview
Table 80. Agilent Technologies Companion Diagnostics Product
Table 81. Agilent Technologies Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 82. Agilent Technologies Recent Developments
Table 83. Life Technologies Company Details
Table 84. Life Technologies Business Overview
Table 85. Life Technologies Companion Diagnostics Product
Table 86. Life Technologies Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 87. Life Technologies Recent Developments
Table 88. GE Healthcare Company Details
Table 89. GE Healthcare Business Overview
Table 90. GE Healthcare Companion Diagnostics Product
Table 91. GE Healthcare Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 92. GE Healthcare Recent Developments
Table 93. Agendia Company Details
Table 94. Agendia Business Overview
Table 95. Agendia Companion Diagnostics Product
Table 96. Agendia Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 97. Agendia Recent Developments
Table 98. Qiagen Company Details
Table 99. Qiagen Business Overview
Table 100. Qiagen Companion Diagnostics Product
Table 101. Qiagen Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 102. Qiagen Recent Developments
Table 103. Genomic Health Company Details
Table 104. Genomic Health Business Overview
Table 105. Genomic Health Companion Diagnostics Product
Table 106. Genomic Health Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 107. Genomic Health Recent Developments
Table 108. Myriad Genetics Company Details
Table 109. Myriad Genetics Business Overview
Table 110. Myriad Genetics Companion Diagnostics Product
Table 111. Myriad Genetics Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 112. Myriad Genetics Recent Developments
Table 113. Advanced Cell Diagnostics Company Details
Table 114. Advanced Cell Diagnostics Business Overview
Table 115. Advanced Cell Diagnostics Companion Diagnostics Product
Table 116. Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 117. Advanced Cell Diagnostics Recent Developments
Table 118. Danaher Company Details
Table 119. Danaher Business Overview
Table 120. Danaher Companion Diagnostics Product
Table 121. Danaher Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 122. Danaher Recent Developments
Table 123. Applied Proteomics Company Details
Table 124. Applied Proteomics Business Overview
Table 125. Applied Proteomics Companion Diagnostics Product
Table 126. Applied Proteomics Revenue in Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 127. Applied Proteomics Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Immunohistochemistry (IHC) Features
Figure 4. In Situ Hybridization (ISH) Features
Figure 5. Next Generation Sequencing (NGS) Features
Figure 6. Global Companion Diagnostics Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Other Case Studies
Figure 11. Companion Diagnostics Report Years Considered
Figure 12. Global Companion Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Companion Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Companion Diagnostics Market Share by Region: 2021 VS 2028
Figure 15. Global Companion Diagnostics Market Share by Players in 2021
Figure 16. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Companion Diagnostics Revenue in 2021
Figure 18. North America Companion Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Companion Diagnostics Market Size Market Share by Type (2017-2028)
Figure 20. North America Companion Diagnostics Market Size Market Share by Application (2017-2028)
Figure 21. North America Companion Diagnostics Market Size Share by Country (2017-2028)
Figure 22. United States Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Companion Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Companion Diagnostics Market Size Market Share by Type (2017-2028)
Figure 26. Europe Companion Diagnostics Market Size Market Share by Application (2017-2028)
Figure 27. Europe Companion Diagnostics Market Size Share by Country (2017-2028)
Figure 28. Germany Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Companion Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Companion Diagnostics Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Companion Diagnostics Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Companion Diagnostics Market Size Share by Region (2017-2028)
Figure 38. China Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Companion Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Companion Diagnostics Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Companion Diagnostics Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Companion Diagnostics Market Size Share by Country (2017-2028)
Figure 48. Mexico Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Companion Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Companion Diagnostics Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Companion Diagnostics Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Companion Diagnostics Market Size Share by Country (2017-2028)
Figure 54. Turkey Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Companion Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Roche Holdings Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 58. Abbott Laboratories Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 60. Agilent Technologies Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 61. Life Technologies Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 62. GE Healthcare Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 63. Agendia Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 64. Qiagen Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 65. Genomic Health Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 66. Myriad Genetics Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 67. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 68. Danaher Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 69. Applied Proteomics Revenue Growth Rate in Companion Diagnostics Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.